{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:08:39Z","timestamp":1779469719392,"version":"3.53.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#498150"],"award-info":[{"award-number":["#498150"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chair","doi-asserted-by":"crossref","award":["CRC-2020-00068"],"award-info":[{"award-number":["CRC-2020-00068"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["TA-1605-08590"],"award-info":[{"award-number":["TA-1605-08590"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI169075"],"award-info":[{"award-number":["R01 AI169075"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA282794"],"award-info":[{"award-number":["R01 CA282794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI139536"],"award-info":[{"award-number":["R01 AI139536"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI039671"],"award-info":[{"award-number":["P01 AI039671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI056299"],"award-info":[{"award-number":["P01 AI056299"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>IL-12p40 heterodimerizes with IL-12p19 and IL-12p35 to produce IL-23 and IL-12, respectively. The functions of IL-12 and IL-23 are best described in T cells in which IL-12 is a potent inducer of Th1 differentiation, whereas IL-23 can amplify Th17 responses in inflammatory diseases. Here we present evidence that mouse IL-12p40 can form a third heterodimer with CD5Like (CD5L). The formation of this new heterodimer, CD5L:p40, is dependent on charged residues and can be induced in myeloid cells under inflammatory conditions such as experimental models of colitis, autoimmune inflammation of the central nervous system, and airway inflammation. We demonstrate that recombinant CD5L:p40 can induce a unique transcriptome and IL-13 expression from effector Th17 cells in a dual-specificity phosphatase 2\u2013dependent manner. We developed a monoclonal antibody that specifically targets CD5L:p40 but not its individual subunits and demonstrate that this blocking antibody exhibits efficacy in reducing an antigen-dependent Th2 response and airway inflammation.<\/jats:p>","DOI":"10.1093\/jimmun\/vkaf348","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:55:34Z","timestamp":1773827734000},"source":"Crossref","is-referenced-by-count":0,"title":["CD5L:p40, a novel heterodimeric regulator of type 2 inflammation"],"prefix":"10.1093","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-6093","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"first","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Broad Institute of MIT and Harvard , Cambridge, MA,","place":["United States"]},{"name":"Biological Sciences Platform, Sunnybrook Research Institute , Toronto, ON,","place":["Canada"]},{"name":"Department of Immunology, University of Toronto , Toronto, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Zaghouani","sequence":"additional","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Wallrapp","sequence":"additional","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Newcomer","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Greenfield","sequence":"additional","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Boyd","family":"Johnson","sequence":"additional","affiliation":[{"name":"Biological Sciences Platform, Sunnybrook Research Institute , Toronto, ON,","place":["Canada"]},{"name":"Department of Immunology, University of Toronto , Toronto, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocky","family":"Barilla","sequence":"additional","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Pawlak","sequence":"additional","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Christian","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard , Cambridge, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R","family":"Burkett","sequence":"additional","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Leabo","sequence":"additional","affiliation":[{"name":"Celsius Therapeutics , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Celsius Therapeutics , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Soto","sequence":"additional","affiliation":[{"name":"BioLegend , San Diego, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena S","family":"Chen","sequence":"additional","affiliation":[{"name":"BioLegend , San Diego, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Monell","sequence":"additional","affiliation":[{"name":"BioLegend , San Diego, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion H","family":"Brown","sequence":"additional","affiliation":[{"name":"Sir William Dunn School of Pathology, University of Oxford , Oxford,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C","family":"Almo","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Albert Einstein College of Medicine , Bronx, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meromit","family":"Singer","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Regev","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard , Cambridge, MA,","place":["United States"]},{"name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology , Cambridge, MA,","place":["United States"]},{"name":"Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology , Cambridge, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K","family":"Kuchroo","sequence":"additional","affiliation":[{"name":"Gene Lay Institute of Immunology and Inflammation, Brigham and Women\u2019s Hospital, Mass General Hospital, and Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Broad Institute of MIT and Harvard , Cambridge, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026052212164604900_vkaf348-B1","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1084\/jem.176.5.1387","article-title":"Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells","volume":"176","author":"D\u2019Andrea","year":"1992","journal-title":"J Exp Med"},{"key":"2026052212164604900_vkaf348-B2","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1073\/pnas.88.10.4143","article-title":"Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor","volume":"88","author":"Gubler","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026052212164604900_vkaf348-B3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.170.3.827","article-title":"Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes","volume":"170","author":"Kobayashi","year":"1989","journal-title":"J Exp Med"},{"key":"2026052212164604900_vkaf348-B4","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1073\/pnas.87.17.6808","article-title":"Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells","volume":"87","author":"Stern","year":"1990","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2026052212164604900_vkaf348-B5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"2026052212164604900_vkaf348-B6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI15751","article-title":"Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12","volume":"110","author":"Becher","year":"2002","journal-title":"J Clin Invest"},{"key":"2026052212164604900_vkaf348-B7","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.4049\/jimmunol.169.12.7104","article-title":"IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination","volume":"169","author":"Gran","year":"2002","journal-title":"J Immunol"},{"key":"2026052212164604900_vkaf348-B8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"2026052212164604900_vkaf348-B9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/s1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"2026052212164604900_vkaf348-B10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.0022-202X.2004.23448.x","article-title":"A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis","volume":"123","author":"Kauffman","year":"2004","journal-title":"J Invest Dermatol"},{"key":"2026052212164604900_vkaf348-B11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"2026052212164604900_vkaf348-B12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell\u2013mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"2026052212164604900_vkaf348-B13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"2026052212164604900_vkaf348-B14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-021-03188-w","article-title":"Skin-resident innate lymphoid cells converge on a pathogenic effector state","volume":"592","author":"Bielecki","year":"2021","journal-title":"Nature"},{"key":"2026052212164604900_vkaf348-B15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"2026052212164604900_vkaf348-B16","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"J\u00e4ger","year":"2009","journal-title":"J Immunol."},{"key":"2026052212164604900_vkaf348-B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"2026052212164604900_vkaf348-B18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4049\/jimmunol.154.1.116","article-title":"Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity","volume":"154","author":"Ling","year":"1995","journal-title":"J Immunol"},{"key":"2026052212164604900_vkaf348-B19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/eji.1830250133","article-title":"Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist","volume":"25","author":"Gillessen","year":"1995","journal-title":"Eur J Immunol"},{"key":"2026052212164604900_vkaf348-B20","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.4049\/jimmunol.158.9.4381","article-title":"In vivo production and function of IL-12 p40 homodimers","volume":"158","author":"Heinzel","year":"1997","journal-title":"J Immunol."},{"key":"2026052212164604900_vkaf348-B21","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.4049\/jimmunol.171.12.6866","article-title":"IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 Receptor \u03b21","volume":"171","author":"Russell","year":"2003","journal-title":"J Immunol"},{"key":"2026052212164604900_vkaf348-B22","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/(SICI)1521-4141(199906)29:06%253C2007::AID-IMMU2007%253E3.0.CO","article-title":"Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits","volume":"29","author":"Wang","year":"1999","journal-title":"Eur J Immunol"},{"key":"2026052212164604900_vkaf348-B23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1084\/jem.20052545","article-title":"Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection","volume":"203","author":"Khader","year":"2006","journal-title":"J Exp Med"},{"key":"2026052212164604900_vkaf348-B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.it.2006.11.002","article-title":"IL-12p40: an inherently agonistic cytokine","volume":"28","author":"Cooper","year":"2007","journal-title":"Trends Immunol"},{"key":"2026052212164604900_vkaf348-B25","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.4049\/jimmunol.1400159","article-title":"Free IL-12p40 monomer is a polyfunctional adaptor for generating novel IL-12-like heterodimers extracellularly","volume":"192","author":"Abdi","year":"2014","journal-title":"J Immunol."},{"key":"2026052212164604900_vkaf348-B26","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","article-title":"CD5L\/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"2026052212164604900_vkaf348-B27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.189.2.413","article-title":"Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily","volume":"189","author":"Miyazaki","year":"1999","journal-title":"J Exp Med"},{"key":"2026052212164604900_vkaf348-B28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1107\/S0907444906029799","article-title":"A time- and cost-efficient system for high-level protein production in mammalian cells","volume":"62","author":"Aricescu","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2026052212164604900_vkaf348-B29","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","article-title":"A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells","volume":"166","author":"Singer","year":"2016","journal-title":"Cell"},{"key":"2026052212164604900_vkaf348-B30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"key":"2026052212164604900_vkaf348-B31","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3892\/etm.2020.8497","article-title":"CD5L-induced activation of autophagy is associated with hepatoprotection in ischemic reperfusion injury via the CD36\/ATG7 axis","volume":"19","author":"Li","year":"2020","journal-title":"Exp Ther Med"},{"key":"2026052212164604900_vkaf348-B32","doi-asserted-by":"publisher","first-page":"38762","DOI":"10.1038\/srep38762","article-title":"A proteolytic modification of AIM promotes its renal excretion","volume":"6","author":"Yamazaki","year":"2016","journal-title":"Sci Rep"},{"key":"2026052212164604900_vkaf348-B33","doi-asserted-by":"publisher","first-page":"eaau1199","DOI":"10.1126\/sciadv.aau1199","article-title":"The IgM pentamer is an asymmetric pentagon with an open groove that binds the AIM protein","volume":"4","author":"Hiramoto","year":"2018","journal-title":"Sci Adv"},{"key":"2026052212164604900_vkaf348-B34","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1038\/s41598-021-84624-9","article-title":"IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development","volume":"11","author":"Hasegawa","year":"2021","journal-title":"Sci Rep"},{"key":"2026052212164604900_vkaf348-B35","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jmb.2008.07.051","article-title":"The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12","volume":"382","author":"Lupardus","year":"2008","journal-title":"J Mol Biol"},{"key":"2026052212164604900_vkaf348-B36","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1093\/emboj\/19.14.3530","article-title":"Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12","volume":"19","author":"Yoon","year":"2000","journal-title":"Embo J"},{"key":"2026052212164604900_vkaf348-B37","doi-asserted-by":"publisher","first-page":"e189566","DOI":"10.1172\/JCI189566","article-title":"Divergent TIR signaling domains in TLR7 and TLR9 control opposing effects on systemic autoimmunity","volume":"135","author":"Leibler","year":"2025","journal-title":"J Clin Invest"},{"key":"2026052212164604900_vkaf348-B38","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/ni.3278","article-title":"The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation","volume":"16","author":"Lu","year":"2015","journal-title":"Nat Immunol"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/3\/vkaf348\/67387238\/vkaf348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/3\/vkaf348\/67387238\/vkaf348.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:16:54Z","timestamp":1779466614000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/doi\/10.1093\/jimmun\/vkaf348\/8527212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkaf348","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]},"article-number":"vkaf348"}}